Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix
PaperCitations, authors & open-access status
A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 66 citations, 2015 year and green oa status.
66
Citations
2015
Year
green
OA Status